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INTRODUCTION
Apornorphine is a non-selective dopaurrne agonist with central and peripheral actiorrs (Anden et al. 1967', Corsini et al. l98l; Creese, 1987) . It has been extensively used as a pharmacological probe of dopaminergic systems in both normal volunteers and psychiatric patients (Checkley, 1980; Meltzer et al. 1984) . ln neuroendocrine challenge paradigms apomorphineinduced increases in plasma grorvth hormone are used as an index ofcentral dopamine receptor function (Checkley, 1980; Lal, 1987) . Recently, an enhanced growth hormone response to apornorphine has been reported to be predictive of women at high risk of affective psychosis af ter childbirth (Wieck er ul. l99l) .
Despite considerable experimental data on apornorphine's central effects in animals, little rs known about the brain areas targeted, functionally, by apomorphine in humans. The use of positron emission tomography (PET) to measure drug-induced changes in regional cerebrai blood flow (rCBF) is potentially a powertul approach to determine brain systems affected by centrally active drugs. Regional cerebral blood flow measurement is, under most circumstances, a valid index of neuronal activity in livo and. in addition, is sensitive to physiological/ belravioural challenges (McCulloch, 1982 , Raichle, 1987 , Posner et ul. 1988 .
Using positron emission tomography (PET) we report the effects on rCBF of single subcutaneous doses ol apomorphine (5 and l0 pglkg) in normal volunteers. Our aims were to determine: (l) the brain areas altered by apomorphine administration. as indexed by changes in rCBF; and (2) rvhetlrer the pattern of rCBF change was consistent with the known distribution of central ascending dopaminergic projections and receptors.
METHOD Subjects
Eighteen right-handed male volunteers (age range 25 36 years) took part in the study which was approved by the Hammersmith Hospital Ethics Committee and the Advisorv Committee on the Administration of Radioactive Substances (ARSA(') UK
Drug administration
Each subject underu'ent six PET measurements of rCBF over an 80 min period. Two measurements of rCBF were undertaken before (t : -12, -2 min), and four measurements after (r: + 15. +25, +45 and +55 min) subcutaneous apomorphine 5, l0 lClkC or placebo (water for injections). Scan times post apomorphine were chosen on the basis of apomorphine kinetics and the induction of centrally mediated neuroendocrine responses. Time to peak plasma concentration following subcutaneous apornorphine is approximately 8 min with an estimated elimination half-lif'e of approrimately 34 min (Gancher et al. 1989 ). Increiises of plasma growth hormone begin approximately l5 min following apomorphine 5 lglkg injection subcutaneously and reach a maximum at approximately 60 min (Costain et al. 1982) . Subjects were blind to the drug administered. Twelve subjects received apomorphine, six subjects received placebo.
Experimental design
Subjects perfbrmed memory tasks during PET scanning. Such standardization of behavioural state may allorv for a reduction in intra-and inter-subject variability in rCBF (Duara et al. 1987) . The behavioural state used for this study was a subspan memory task performed during the lst, 3rd and 5th scan. A mernory task was chosen as the reported experiment formed part of a larger study investigating interactions between monoaminergic drugs and memory processes (Friston et al. 1992) . Subjects were asked to remember and immediately recali a series of five-rvord lists presented auditorily. Nine live-word lists were presented over the two minutes of the PET acquisition scan. Words were presented at the rate of one word every two seconds. Words were high frequency, concrete, inageable and were taken from the Oxford Psycholnguistic Data Base (Quinlan, 1992) . In this paper the effect of apornorphine on rCBF under the subspan task alone is reported. A more complex memory task was performed during the 2nd, 4th and 6th scans; the effects of this task and apomorphine-memory task interactions on rCBF will be reported separately (see Friston et ol. 1992 for a preliminary report). Apomorphine or placebo was given after the 2nd scan. Subjects' eyes were closed throughout scanning.
PET scanning
Scans were obtained using a CTI nodel 931-08/12 PET scanner (CTI, Knoxville, TN, USA) (Spinks et ql. 1988\. Scans were reconstructed using a Hanning filter with a cut-off frequency of 0'5 giving a transaxial resolution of 8'5 mm full width at half maximum and an axial resolution of 6'15 mm for each of 15 transverse planes with a resulting totai field of view of l0'13 cm in this direction. To index rCBF. subjects inhaled trace amounts of C"Or. mixed with air, at a concentration of 6 MBq/ml and a flow rate of 500 ml/min through a disposable oxygen face mask tbr a period of 2 min. Two PET scans were collected over a oeriod of 2'5 min beginning 0'5 min befbre the inhalation of C15O" (background scan duration 0'5 mrn, second sc:rn duration 2'0 min) (adapted from Lammertsma et al. 1990) . In this study, the integrated counts per pixel for the 2 minute build-up phase of radioactivity in the brain during C"O, inhalation were used as an index of rCBF (Fox & Mintun. 1989 ).
Measurement of plasma growth hormone
Apomorphine-induced increases in plasma growth hormone were determined from samples obtained from blood drawn frorn an in-drvelling venous cannula (t ---20, 0, 30 and 60 min post-apomorphine/placebo). Plasma growth hormone was measured by radioimmunoassay as previously described (Cowen et ul. 1985) .
Measurement of side effects of apomorphine administration
Stress and arousal were assessed on three occasions (t : -l5 min pre-apomorphine/ placebo, + 30 and * 60 min. post-apontorphine/placebo) on a 24-item qnestionnarre (Mackay et al. 1978) .In addition, subjects rated nausea, light-headedness and drowsiness on visual analogue scales.
Data analysis
Each reconstructed rCBF scan consisting of l5 primary transverse planes rvas interpc'rlated to 43 planes to render the voxels approximately cubic. The data werc then transformed into a standard stereotactic space (Friston et al. 1989, l99lrr) . Such transfbrmation of the data allows for pixel by pixel averaging ofdata across subjects. In the standard space I voxel represents 2x2x4mm in the .r, J' and : dimensions, respectively, allowing direcl cross reference to the anatonical features in the standard stereotactic atlas (Talairach & Tournoux. 1988) . A Gaussian filter (20 mm FWHM) was applied to smooth each in-rage to account lbr inter-subject differences in gyral and functional anatomy and to suppress high frequency noise in the images. Differences in global activity within and between subjects were removed by analysis of covariance (Wildt & Ahtola. 1978 ) on a pixel by pixel basis with global counts as col'ariate and regional activity across subjects lbr each task as treatment. This procedure was undertaken as inter-and intra-subject dill-erences in global CBF may reduce the likelihood of detecting alterations in rCBF following physiological stimulation (Friston et al. 1990 ). For each pixel, in stereotactic space, the analysis of covariance generated 6 condition-specific (i.e. scans l-6) mean rCBF equivalent values (norrnalized to 50 ml/dl/niin) and an associated error variance. This error variance was computed independently for the placebo and apomorphine 5 and 10 pglkC groups using a completely randomized biock design ANCIOVA. The changes of interest rvere rCBF changes attributable to apomorphine that were statistically greater than those induced by placebo. This represents zrn interaction (predrug r,. post-drug x placebo u. apomorphine). This interaction term rvas computed using the I statistic, with the appropriate contrasts (Hand & Taylor, 1991) and adjusted error variance. The resulting set of I values constitutes a statistical paran.retric map (SPM(I)) (Friston at ul. I99l b). With so nany comparisons being made, many I values will reach conventional levels of significance by chance. Therefore, the 'omnibus' significance of the SPMs was assessed, using the ;: statistic. by comparing the expected and observed number of / values which exceeded a threshold of P < 0'001. Ii this statistic was significant (for a given contrast) the location of all pixels with a / value corresponding to P < 0'001 was used to define the profile of a;romorphine-induced rCBF chirnges compared to placebo. The results presented are rCBF data from the first pre-drug scan (scan l) conrpared to post-drug scans (3 + 5). apomorphinc -5 or l0 pglkg compared to placebo. Because of the smoothing fiiter used (see above) the final individual values for rCBF at any one pixel represent blood flow in a weighted spherical domain of about 20 mm diarleter. Image analysis was per{brmed r-rsing SPM software (MRC Cyciotron Unit, London, UK) on a SPARC I workstation (Sun Microsystems Inc.. Surrey. UK) using an inteructive imlgc analysis software package (ANALYZE), Biodynamic Research Unit, Mayo Clinic, USA). Calculations and image matrix manipulations were performed in PRO MATLAB (Mathu,orks Inc.. New York).
RESULTS
Apomorphine-induced changes in rCBF' represent relative increases or decreases cornpared to placebo. It should be noted that increases and decreases of rCBF-may also have occurred outside the axial field of view of the scanner (see Fig. 1 ).
Observed and expected distribution of t statistic for post-drug (scans 3+5) r'ersus pre-drug (scan 1) comparisons Significant differences in the observed and expected distribution of the / statistic (at the threshold of P < 0'001) lor apomorphine (10 ag/kg)-induced increases in rCBF compared to placebo were observed (tt 40'1. df l, P < 0'001). Using the;'test there was no significance for apomorphine (10 4g/kg)-induced decreases (X' : 0, df 1). Apomorphine (5 pglkg)-induced increases failed to reach significance at the threshold of P < 0'001 but were significant at P < 0'01 (,y':7'10, df l). Apor'orphine (5 7zg/kg)-induced decreases were not significant (X'z : 0, df l).
Sites of apomorphine-induced increases of regional cerebral blood flow Two foci of increased regional cerebral blood flow were observed in the anterior cingulate cortex (2, 40, 4 mm, and 2, 34, 24 mm in Talairach and Tournoux coordinates in the,r, -t' and z plane respectively) following apomorphine 10 pglkg (Table I, Fig. l. Fig. 2 ). Increased rCBF was also seen in the right prefrontal cortex following apomorphine (10 4g/kg).
For apomorphine (5 trglkg) i,l similar pattern of anterior cingulate increases in rCBF was noted ( 4, 42. 0 mm and -8, 22, 24 mm in Talairach and Tournoux coordinates in the,v, -1, and : plane respectively) (see Fig. l) although the X' test for this comparisorl lailed to achieve significance at the threshold of P < 0'001.
Plasma growth hormone following apomorphine (5 and l0 pglkg)
Courpared to placebo, plaslna growth hormone increased following aponlorphine administratiorr at 5 and l0 pglkg. Tl.ris increase was statistically significant for the l0 7.rg/kg dose (growth hormone, post-drug at 60min-_pre-drug; apomorphine 107rg/kg 69129* mlu/I, apomorphine 5 pglkg 24+32 mlU/l and placebo 2+3 nrlU/I, *P < 0'01 Student's r test unpalred).
Memorl' performance, stress, arousal and side eflects of apomorphine administration Memory performance in the five-word-list memory task was assessed as the total percentage of words correctly recalled during each scan. Both doses of apomorphine had no effect on the percentage of words correctly recalled (apomorphine l0 7rg/kg : 98'5, 98'7, 98'0 oh and apomorphins -5 7rg/kg: 98'0, 98'0 and 100%, means lbr scans l, 3 and 5 respectively). Measures of stress decreased during the time of the PET study in both apomorphine 5 yglkg, l0 pg/kg and placebo treated groups. However, arousal it.rcreased in the apornorphine l0 4glkg group (apomorphine 10 p,glkg:' stress l6*5 to 12+2, arousal 3*4 to 4*9, apomorphine 5 pglkg; stress l7 * 2 to l3 * l, arousal -| + 2 to -6*4, placebo group;stress 19 *2to 14*2, arousal -1+2Io -7 *3, means*s.o.). Transient and mild nausea was noted by 3 subjects following apomorphine 10 4g/kg (data not shown).
DISCUSSION
A remarkably similar profile of apomorphineinduced increases of rCBF in the anterior cingulate was observed in both the apomorphine 5 pelke and l0 t,ClkC treated groups (Fig. l) . The foci of these anterior cingulate activations differed by a maximum of 10, l2 and 4 nrm only in the .r:, r' and i planes for the two doses of apomorphine and therefore are unlikely to reflect real differences in the sites of activation between doses. In keeping with the drug's rapid onset and short duration of action (Gancher e,/ a1. 1989 ) these increases were greater at the first post-apomorphine l0ag/kg scan (t: 15 min) than the second (t : + 45 min) (see Table I and Fig. 2 ). Apomorphine-induced increases of rCBF were also seen in right prefrontal cortex at the l0 1rg/kg dose (Fig. l) and the left prefrontal cortex but only at a lower threshold of P < 0'0 I (data not shown). The similarity in the location of rCBF increases in the anterior cingulate with both doses of apomorphine is strong evidence for a significant biological effect. It also suggests that non-specific side effects (transient nausea, increased arousal), seen following apomorphine l0 but not 5 yglkg. are unlikely to be a sulicient explanation lor the changes rn rCBF.
The apornorphine-induced increases of rCBF in this study are in broad asreement with the reported stimulatory effects of dopamrne agonists on cerebral blood flow (CBF') in animals and man. In man, the dopamine agonists apomorphine, piribedil, bromocriptine and the dopamine precursor l-DOPA all increase CBF (Guell er al. 19821-Bes et al. 1983; Leenders et al. 1985; Sabatini et al. 1991) . In the antresthetized baboon apomorphine (0'02 0'5 mg/kg) also 2 7l t 1 86 0.74 + 1.28 r '97 + 1.39 -0.38 + 1.72 Ftc;. 2. rCBF increascs in thc antcrior cingulate following irpomorphine 1l0agi kg).
Valucs on ordinate are cerebral blood flow equivalcnts (ml/dl/min) for individual subjccts, normalizcd to r global blood flcru,trt' 50 ml/dl/ntin. in thc anterior cinguhte at the two foci ol'maximal change in rCBF (see Table l ). A. Anterir)r cingulate at coordinirtcs 2. 34. 24 (nm in .r.,r'and z plancs rcspectively). B. Anterior cingulate at Talairach und Tournoux coordinatcs 2. 40. 4 (mm in r. ' and: plancs rcspcctively). [. Individual values for rC]BF. The abscissa refers to PET scan scquence: l. {irst scan; 2. third scan; I, fifth scan. Apomorphine was given between points I and 2 on the abscissa. increases CBF (McCulloch & Murray-Harper, 1977) . ln agreement with our results in some human studies a selective increase in prefrontal rCBF has been noted (Bes et al. 1983; Daniel er al. 1991) . In addition, a relative increase rn glucose metabolism in frontal areas has been reported by Cleghorn et al. (1991) following apomorphine. In the single tomographic slice examined no anterior cingulate changes were noted (Cleghorn et al. 1991) . Despite agreement on the direction of the expected change in CBF, the mechanism of dopamine agonist induced changes in CBF is contentious (see McCulloch et ul. 1982 ; Leendels et al. 1985) . Either of two mechanisnls might account for the observed effects: a direct vasodilatory effect of apomorphine on cerebral blood vessels or an effect of apomorphine on neuronal firing, with consequent changes tn glucose metabolism and rCBF. This issue is unresolved at present. For example, in Parkinsonian patients apomorphine (0'3 mg s.c.) increased global CBF but this effect was blocked by the peripheral dopamine receptor blocker domperidone (20 mg t.d.s. for 48 h), suggesting a primary vasodilatatory effect of apomorphine (Sabatini et ul. l99l) . In contrast, the increase in CtsF in normal volunteers following the dopamine agonist piribedil was not blocked by domperidone (30 mg 20 min before piribedil) (Guell et ul. 1982) suggesting a direct metabolic effect. Despite the evidence for dopamrne receptors in the cerebral vasculature and the vasodilatory effects of dopamine agonists on cerebral vessels in vitro and rn uir,o (Toda, 1976; Edvinsson et al. 1918 Edvinsson et al. , 1985 , there is strong evidence from studies in the conscious rat and the anaesthetized baboon that apomorphine induced changes in cerebral blood flow are secondary to changes in cerebral rnetabolism (McCulloch & Murray-Harper, 1916; McCulloch et al. 1982) . In support of a direct effect of apomorphine on neuronal firing, Cleghorn (1991) has recently reported increased posterior fiontal metabolism in normal volunteers following apomorphine l0 7rg/kg. The discrete regional location of apomorphineinduced increases in rCBF in this study would also favour an explanation via changes in neuronal activity.
Apomorphine stirnulates dopamine autoreceptors located on cell bodies or dendrites of dopaminergic neurones but also acts on dopirnrinersic reccptors post svnaptic to dopamine neurones (Aghajanian & Bunney, 1977) . Either or both sites might be the pharmacological site of action of apomorphine at which the effects on rCBF are mediated. If a direct post-synaptic effect on dopamine receptors in the anterior cingulate is postulated then D, receptor stimulation would seem more likely as dopamine D, receptors are in higher concentration than clopamine I)" receptors in cortical areas (Camps et a|.1989; Cortes et ul. 1989) . Ifa direct action on pre-synzrptic doparnine autoreceptors is postulated then rCBF changes might be manifest ln areas of dense dopaminergic terrninal innervation. Unlike the restricted dopaminergic innervation of the rat cortex. in man. most cortical areas are innervated. However, innervation ts most dense in the anterior cingulate and motor cortex where dopaminergic projections are to all cortical layers (Berger et ul.1991) . Whatever the pharrnacological site of action of apomorphine in this study, equivalent studies with dopaminergic agonists in animals would suggest that these effects will best be understood in relation to neuroanatomical circuits (McCulloch, 1982; Soncrant et a/. 1986 ). of which mesocortical dopaminergic projections are likely to be an important factor. No striatal activations were noted following either dose of apomorphine. Interestingly, Cleghorn el al. (1991) also reported no changes in striatal activity, indexed by glucose consumption, following apomorphine administration in normal volunteers. Mismatches between dnrg effects and receptor distributions/terminal innervation patterns are clearly described in the animal functional imaging lield (McCulloch, 1982) . In addition, putative physiological differences between mesostriatal and mesoneocortical dopaminergic systems (De Keyser et al. 1990 ) might account for the differential effects of apomorphine in frontal and striatal areas.
Subjects were studied under the condition of five-word-list learning. Memory task induced activations of neuronal circuits may therefore have masked apomorphine effects in certain brain areas. However, any baseline condition, even a 'resting state', is likely to be associated with activations in distributed networks (e.g. attentional systems). Therefore, drug effects will always be manifest in the context of the integrated functioning of activated neuronal systems. As apomorphine did no1 afl-ect performance in the five-word-list memory task apomorphine's effects are unlikely to represent an alteration in the magnitude or pattern of memory task activation pre-drug l'e,rsas postdru-s. Further pharmacological characterization with dopamine antagonists is needed to provide a conclusive pharmacological interpretation of our results. Despite this limitation, the results suggest that mapping of central drug effects with PET with serve as an extension to the more established neuroendrocine challenge paradigms for investigating central neurotransmission in psychiatric illness. Thus, while apomorphineinduced increases in plasma growth hormone reflect dopaminergic receptor sensitivity in the hypothalamus (Checkley, 1980) , clearly other cortical and limbic structures are more likely candidates for dopaminergic functional abnormalities in psychiatric illness. Apon'rorphineinduced changes in cingulate rCBF rnay provide a direct index of central dopaminergic function in a brain area not currently accessible with neuroendocrine challenses.
